1. Steven M Pollard  Is a corresponding author
  2. Maria Angeles Marques-Torrejon
  1. University of Edinburgh, United Kingdom

To construct the mammalian brain, the right neurons must be produced in the right place at the right time. For example, the outer layer of the brain, the cortex, consists of six layers of neurons and is built up one layer at a time. This is achieved by controlling how cells called apical progenitors become basal progenitors, which then specialize into new neurons (Gotz et al., 2002; Figure 1). If the apical progenitors become basal progenitors too soon, several developmental brain abnormalities can result, the brain may be too small (a condition known as microcephaly), or the layering of the cortex may be disrupted. Now, in eLife, Gail Mandel of the Oregon Health and Science University and co-workers – including Tamilla Neichiporuk as first author – report that a protein called REST has an unexpected role in protecting the genome of these progenitor cells (Nechiporuk et al., 2016).

REST regulation in embryonic neurogenesis.

The REST protein is expressed in apical progenitors (green cells) and represses the expression of genes that are necessary for neurons (pink cell) to develop. Left: REST maintains genome stability, protecting the DNA of the apical progenitor cell during S phase (the phases of the cell cycle are shown in the yellow and white oval). The cells then reduce the production of REST precisely at the apical progenitor cell cycle exit (during G1 phase). This ensures that new neurons develop properly. Right: In the absence of REST, the DNA of the apical progenitor cell becomes damaged during S phase, preventing the subsequent production of basal progenitors and neurons.

The identity of a cell is determined to a large extent by which of its genes are transcribed. Therefore, when a new neuron first develops from a progenitor cell, a process of 'transcriptional resetting' must occur so that the genes that need to be expressed in mature neurons can be activated. The REST protein, first identified in 1995, is expressed in all cells except for mature neurons, and so researchers immediately suspected that it was involved in repressing neuronal genes (Schoenherr and Anderson, 1995; Chen et al., 1998; Bruce et al., 2004).

Support for this idea came from experiments that showed that REST binds to and represses genetic elements that are associated with many genes that are specific to mature neurons. As part of this repression, REST recruits a series of repressor complexes that alter how the gene is packed into a structure called chromatin. However, a previous study involving knockout mice who could not produce the REST protein failed to identify any significant abnormalities in the developing or adult brain (Gao et al., 2011; Aoki et al., 2012: Yang et al, 2012). The role of REST has therefore remained uncertain.

Nechiporuk et al. – who are based in the US and Germany – have now used a technique called conditional genetic ablation to explore the role of REST in neural progenitors. This revealed an unexpected requirement for REST in protecting the genome of the apical progenitors. Loss of REST induces DNA damage during the S phase of the cell cycle: this is the phase during which DNA is replicated. A consequence of this damage is the acquisition of chromosomal abnormalities in the apical progenitors. This triggers cells to commit suicide – following the orders of a protein called p53 – and the result is microcephaly. Nechiporuk et al. also show that the combined loss of REST and p53 results in the formation of a highly aggressive brain tumour called a glioblastoma. REST therefore performs a dual role during brain development: it protects the progenitor cells from genetic catastrophe, and it silences neuronal gene expression until the time is right.

These findings came as a surprise, given the results of the previous REST knockout studies. However, in a series of elegant experiments Nechiporuk et al. showed that these earlier mouse models did not fully delete the REST coding sequences: the knockout mice still produced a C-terminal peptide that was able to recruit the repressor complexes that helped to silence certain genes. This is a valuable lesson for all researchers – knocking out a gene does not always result in a complete loss of function.

Why does the premature removal of the repressor complexes recruited by REST inflict widespread genomic damage? One possibility proposed by Nechiporuk et al. is that the associated loss of chromatin repression might lead to a subset of neuronal genes being incorrectly transcribed. Thus, REST seems to provide a ‘license’ for progenitors to transform into their final neuronal form by guarding the genome and preventing the premature transcription of genes specific to mature neurons. These new findings address a question that has received little attention to date – how are genome maintenance and transcriptional control coordinated as new neurons develop from progenitor cells?

As with all interesting discoveries, many new questions arise: how is REST protecting neuronal gene integrity during S-phase? How are the processes of cell cycle exit, chromatin repression, and the DNA replication timing coordinated during the birth of new neurons? New insights into how REST orchestrates gene regulation during the construction of the nervous system will clearly enhance our understanding of diseases such as microcephaly and brain cancer. It seems that for neural progenitors, a little REST is what it takes to ensure you reach your full potential!


Article and author information

Author details

  1. Steven M Pollard

    MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom
    For correspondence
    Competing interests
    The authors declare that no competing interests exist.
  2. Maria Angeles Marques-Torrejon

    MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.

Publication history

  1. Version of Record published: January 8, 2016 (version 1)


© 2016, Pollard et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.


  • 1,693
    Page views
  • 180
  • 1

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Steven M Pollard
  2. Maria Angeles Marques-Torrejon
Neurogenesis: Give it a REST!
eLife 5:e12615.

Further reading

    1. Cell Biology
    2. Developmental Biology
    Eunjin Cho, Xiangguo Che ... Tae-Hoon Lee
    Research Article

    Peroxiredoxin 5 (Prdx5) is involved in pathophysiological regulation via the stress-induced cellular response. However, its function in the bone remains largely unknown. Here, we show that Prdx5 is involved in osteoclast and osteoblast differentiation, resulting in osteoporotic phenotypes in Prdx5 knockout (Prdx5Ko) male mice. To investigate the function of Prdx5 in the bone, osteoblasts were analyzed through immunoprecipitation (IP) and liquid chromatography combined with tandem mass spectrometry (LC–MS/MS) methods, while osteoclasts were analyzed through RNA-sequencing. Heterogeneous nuclear ribonucleoprotein K (hnRNPK) was identified as a potential binding partner of Prdx5 during osteoblast differentiation in vitro. Prdx5 acts as a negative regulator of hnRNPK-mediated osteocalcin (Bglap) expression. In addition, transcriptomic analysis revealed that in vitro differentiated osteoclasts from the bone marrow-derived macrophages of Prdx5Ko mice showed enhanced expression of several osteoclast-related genes. These findings indicate that Prdx5 might contribute to the maintenance of bone homeostasis by regulating osteoblast differentiation. This study proposes a new function of Prdx5 in bone remodeling that may be used in developing therapeutic strategies for bone diseases.

    1. Developmental Biology
    Greta Rossi, Gabriele Ordazzo ... Vania Broccoli
    Research Article Updated

    Wolfram syndrome 1 (WS1) is a rare genetic disorder caused by mutations in the WFS1 gene leading to a wide spectrum of clinical dysfunctions, among which blindness, diabetes, and neurological deficits are the most prominent. WFS1 encodes for the endoplasmic reticulum (ER) resident transmembrane protein wolframin with multiple functions in ER processes. However, the WFS1-dependent etiopathology in retinal cells is unknown. Herein, we showed that Wfs1 mutant mice developed early retinal electrophysiological impairments followed by marked visual loss. Interestingly, axons and myelin disruption in the optic nerve preceded the degeneration of the retinal ganglion cell bodies in the retina. Transcriptomics at pre-degenerative stage revealed the STAT3-dependent activation of proinflammatory glial markers with reduction of the homeostatic and pro-survival factors glutamine synthetase and BDNF. Furthermore, label-free comparative proteomics identified a significant reduction of the monocarboxylate transport isoform 1 (MCT1) and its partner basigin that are highly enriched on retinal glia and myelin-forming oligodendrocytes in optic nerve together with wolframin. Loss of MCT1 caused a failure in lactate transfer from glial to neuronal cell bodies and axons leading to a chronic hypometabolic state. Thus, this bioenergetic impairment is occurring concurrently both within the axonal regions and cell bodies of the retinal ganglion cells, selectively endangering their survival while impacting less on other retinal cells. This metabolic dysfunction occurs months before the frank RGC degeneration suggesting an extended time-window for intervening with new therapeutic strategies focused on boosting retinal and optic nerve bioenergetics in WS1.